Company / PP&E (Net)
Exelixis PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$99.0M
FY2025
5-year range
$99.0M / $128.7M
FY2021-FY2025
Trend
-17.1%
vs FY2024
Sector context
#50 of 193
Health Care
What the data says
At $99M, Exelixis's pp&e (net) ranks #50 of 193 in the Health Care sector. Declined from $129M to $99M over the past 2 years.
Based on SEC 10-K filings.
$99M in FY2025 with a 5-year CAGR of +8.0%.
Declined from $129M to $99M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -3.6%
- 5-Year CAGR
- +8.0%
- 10-Year CAGR
- -
Sector benchmark
#50 of 193 in Health CareTop 26% of 193This company $99.0M Sector average $777.6M
▼
-87.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.0%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 17.1% year-over-year.
- Ranks #50 out of 193 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $99.0M | -17.1% |
| FY2024 | $119.4M | -7.3% |
| FY2023 | $128.7M | +16.4% |
| FY2022 | $110.6M | +6.3% |
| FY2021 | $104.0M | +54.4% |
| FY2020 | $67.4M | +37.8% |
| FY2019 | $48.9M | +89.9% |
| FY2018 | $25.7M | +0.0% |
| FY2017 | $25.7M | +1143.0% |
| FY2016 | $2.1M | +44.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026